Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism.
Maitland-van der Zee
Anke-Hilse
AH
Klungel
Olaf H
OH
Leufkens
Hubertus G M
HG
de Boer
Anthonius
A
Stricker
Bruno H Ch
BH
Hofman
Albert
A
Witteman
Jacqueline C M
JC
van Duijn
Cornelia M
CM
Kastelein
John J P
JJ
D000368:Aged; D003327:Coronary Disease / Q000235:genetics / Q000401:mortality* / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007703:Peptidyl-Dipeptidase A